1999
DOI: 10.1183/09031936.99.13366899
|View full text |Cite
|
Sign up to set email alerts
|

Aerosol recovery from large-volume reservoir delivery systems is highly dependent on the static properties of the reservoir

Abstract: Aerosol recovery from large-volume reservoir delivery systems is highly dependent on the static properties of the reservoir. M.J. van der Veen, J.S. van der Zee. #ERS Journals Ltd 1999. ABSTRACT: In this study, the role of electrostatic fields on aerosol recovery from a system with a large collapsible reservoir (30 L) was investigated. In addition, the efficacy of the reservoir method for bronchial challenge procedures was assessed in vivo.Aerosol recovery was determined by measuring the fraction of aerosol (0… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
11
0

Year Published

2001
2001
2007
2007

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 17 publications
(11 citation statements)
references
References 11 publications
0
11
0
Order By: Relevance
“…Bronchial allergen challenge was performed by using a reservoir aerosol delivery system as described previously [15, 16]. Briefly, a collapsible reservoir of approximately 30 L, made of static field dissipative material (RCAS 1206, Richmond, Redlands, CA, USA) and filled with dry air, was connected to a highly efficient jet nebulizer (Mallinckrodt Diagnostica, Petten, the Netherlands) producing an allergen aerosol from 0.5 mL allergen solution.…”
Section: Methodsmentioning
confidence: 99%
“…Bronchial allergen challenge was performed by using a reservoir aerosol delivery system as described previously [15, 16]. Briefly, a collapsible reservoir of approximately 30 L, made of static field dissipative material (RCAS 1206, Richmond, Redlands, CA, USA) and filled with dry air, was connected to a highly efficient jet nebulizer (Mallinckrodt Diagnostica, Petten, the Netherlands) producing an allergen aerosol from 0.5 mL allergen solution.…”
Section: Methodsmentioning
confidence: 99%
“…The subjects inhaled either placebo (vehicle) or salmeterol (4 ϫ 25 g [100 g total]; GlaxoSmithKline, Zeist, the Netherlands) using a metered-dose inhaler attached to a Volumatic (750 mL; GlaxoSmithKline); 30 mins later, they inhaled either normal saline or LPS (from Escherichia coli O26: B6, 100 g dissolved in normal saline; SigmaAldrich, St. Louis, MO) using a large-volume reservoir delivery system as described previously (31,32). Hence, four groups of eight subjects were studied: placebo/saline, salmeterol/saline, placebo/LPS, and salmeterol/LPS.…”
Section: Subjectsmentioning
confidence: 99%
“…The study was approved by the Institutional Ethics and Research Committees, Academic Medical Center, University of Amsterdam, and written informed consent was obtained from all subjects before enrolment in the study. The subjects inhaled normal saline (n58) or LPS (n58; from Escherichia coli O26:B6, 100 mg; Sigma-Aldrich, St Louis, MO, USA) using a largevolume reservoir delivery system as previously described [8,9]. LPS was purified by phenol extraction and had a protein content ,3%; this specific LPS preparation has been used by the authors' and other laboratories in earlier studies with human volunteers [10][11][12][13].…”
Section: Study Subjects and Designmentioning
confidence: 99%